Authors: | Denlinger, CS; Carlson, RW; Are, M; Baker, KS; Davis, E; Edge, SB; Friedman, DL; Goldman, M; Jones, L; King, A; Kvale, E; Langbaum, TS; Ligibel, JA; McCabe, MS; McVary, KT; Melisko, M; Montoya, JG; Mooney, K; Morgan, MA; O'Connor, T; Paskett, ED; Raza, M; Syrjala, KL; Urba, SG; Wakabayashi, MT; Zee, P; McMillian, N; Freedman-Cass, D |
Article Title: | Survivorship: sexual dysfunction (female), version 1.2013. |
Abstract: | Cancer treatment, especially hormonal therapy and therapy directed toward the pelvis, can contribute to sexual problems, as can depression and anxiety, which are common in cancer survivors. Thus, sexual dysfunction is common in survivors and can cause increased distress and have a significant negative impact on quality of life. This section of the NCCN Guidelines for Survivorship provides screening, evaluation, and treatment recommendations for female sexual problems, including those related to sexual desire, arousal, orgasm, and pain. |
Journal Title: | Journal of the National Comprehensive Cancer Network : JNCCN |
ISSN: | 1540-1413; 1540-1405 |
Publisher: | Unknown |
Date Published: | 2014 |